FlandersBio on Twitter

Follow us on Twitter

Archive for January 2015 - News

Archive for January 2015 - Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

Ventana seeks FDA premarket approval for ALK IHC companion diagnostic to benefit lung cancer patients

30.01.2015

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced its FDA submission for premarket approval (PMA) of the VENTANA ALK (D5F3) CDx Assay. The companion diagnostic (CDx) immunohistochemistry (IHC) test is designed to identify ALK(1)-positive lung cancer patients that may benefit from treatment with targeted therapy that inhibits the ALK gene. This submission was the fourth and final module and application required by the FDA’s PMA process. read more

Biogazelle has established a quality management system and is ISO 17025 accredited for gene expression services

29.01.2015

Biogazelle has established a quality management system and is ISO 17025 accredited for gene expression services (Belac, 528-TEST). read more

Esperite (ESP) invests in multimillion largest clinical Genetic center and aims for pole position in Europe

29.01.2015

ESPERITE, the European leader since 2000 in the stem cells life science business, is launching unique new-generation genetic tests. Risk-free, convenient, affordable and accurate tests with results available in a few days. ESPERITE eases its clients the key genetic information to personalize their health-related decisions, fostering a new culture of consumer empowerment towards a proactive approach to health. read more

European Commission’s favourable decision on wage withholding tax partial exemption for Young Innovative Companies

29.01.2015

On Friday 23 January 2015, the European Commission issued a positive decision regarding the compatibility of the application of the wage withholding tax partial exemption for Research & Development by Young Innovative Companies (“YICs”) with the internal market. The European Commission’s decision has not yet been published but it is understood that this positive decision covers the partial exemption’s application by YICs up to 30 June 2014. read more

genae buys e-novex

27.01.2015

genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced today the acquisition of e-novex, a leading provider of electronic data tools that change medical research. read more

AMATSIGROUP NEEMT SEPS PHARMA BELGIË OVER OM ZO HAAR INTERNATIONALE EXPANSIE VERDER TE ZETTEN EN HAAR EXPERTISE OP HET VLAK VAN FORMULATIES VERDER TE VERSTERKEN

26.01.2015

AMATSIGROUP, de Franse nummer 1 in de levering van diensten op het vlak van ontwikkeling van farmaceutische producten voor mensen en dieren, kondigt de overname van het Belgische bedrijf SEPS Pharma aan. SEPS Pharma levert diensten voor geneesmiddelenontwikkeling, zoals ontwikkeling van de preformulatie en de formulatie, analytische geneesmiddelenontwikkeling, procesontwikkeling en preklinische productie. read more

Promethera® Biosciences reshapes its leadership team

26.01.2015

Promethera Biosciences, a Belgian biotechnology company developing Promethera® HepaStem, a cell-based therapy for the treatment of in-born errors of metabolism and acquired liver diseases, today announces the resignation of Eric Halioua from his post as CEO of Promethera and all other functions within the company. He has decided to leave in order to concentrate on other projects. read more

Gilde Healthcare raises a €100 million lower mid-market healthcare services fund

22.01.2015

Gilde Healthcare, the private equity firm dedicated to the healthcare sector, today announces the first and final close of its €100 million Healthcare Services fund, Gilde Healthcare Services II. The new fund will support the growth of healthcare service companies in the Benelux and Germany. read more

ThromboGenics Appoints Emmanuèle Attout as Independent Non-Executive Director

22.01.2015

ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, announces that its Board of Directors has nominated Emmanuèle Attout to be its new Independent non-executive director. Mrs. Attout will join the Audit Committee of the Company. read more

Delta Lloyd notify of 4.96% shareholding in Galapagos

22.01.2015

Galapagos NV (Euronext: GLPG) received a transparency notification from Delta Lloyd N.V. read more

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Back to top

Print